Lupin receives FDA approval for generic Ultram ER tablets
BALTIMORE — Lupin has received final approval from the Food and Drug Administration for its version of a drug designed to treat moderate to moderately severe chronic pain in adults who require around-the-clock treatment for an extended period of time.
Lupin said that it received final approval for its abbreviated new drug application for tramadol hydrochloride extended-release tablets in the 100-mg, 200-mg and 300-mg strengths. The drug is a generic version of Ultram ER tablets, which is marketed by Johnson & Johnson subsidiary Ortho-McNeil-Janssen Pharmaceuticals.
Tramadol HCl ER tablets is a centrally acting synthetic analgesic in an extended-release formulation, Lupin said. Annual sales for the product totaled approximately $132 million for the 12 months ended in June, according to IMS Health data.
Report: Former Rite Aid vice chairman released from prison
CAMP HILL, Pa. — Franklin Brown, the former vice chairman at Rite Aid, was freed from jail on Wednesday, according to the Associated Press.
Brown, who was initially sentenced to 10 years in prison for taking part in a $1.6 billion accounting scandal, was released following a resentencing hearing. He served six years of his sentence. An appeals court overturned Brown’s sentence in May, AP said.
CVS, retailers promoting flu shot availability sooner than later
LEBANON, Pa. — This CVS location in central Pennsylvania already has started touting the convenience and affordability in relation to its flu vaccination services. And they’re not alone. Now that immunizing pharmacists can administer inoculations in all 50 states, the flu shot season represents a prime opportunity to raise awareness around other vaccines, including back-to-school vaccines and travel vaccines.